Showing results (111-120 of 471) with videos related to
Sort By:
Pageof 48
Journal of Clinical Pathology|July 1, 1981
Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhoodN J Gwavava, C R Pinkerton, J F Glasgow, et al.British Journal of Cancer|September 1, 1991
Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study GroupC R Pinkerton, I Hann, O B Eden, et al.Clinics in Laboratory Medicine|January 19, 1999
Toxicology and adverse effects of drugs used for immunosuppression in organ transplantationA T Philip, B GersonLeukemia|June 1, 1997
Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftmentS Singhal, R Powles, J Treleaven, et al.European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocolsA Atra, C R Pinkerton, E Bouffet, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 22, 2012
A stable-isotope HPLC-MS/MS method to simplify storage of human whole blood samples for glutathione assayR L G Norris, M Paul, R George, et al.Medical and Pediatric Oncology|July 24, 2001
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of ageD A Tweddle, C R Pinkerton, I J Lewis, et al.European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG)A Davidson, R Gowing, S Lowis, et al.Skull Base Surgery|December 16, 2006
A new clinical entity mimicking meningioma diagnosed pathologically as rosai-dorfman diseaseM Simos, P Dimitrios, T PhilipBulletin Du Cancer|July 1, 1995
[Methodology and legitimacy of French clinical trials in primary chemoprevention of cancers. The point of view of the National Federation of French cancer centers]F Eisinger, D Maraninchi, T PhilipPageof 48